Patent Assignment
Reel/Frame 061726/0125
Assignment of Assignor's Interest
Recorded: 2022-11-10
Pages: 5
Assignor
MILLENNIUM PHARMACEUTICALS, INC.
Executed: 2021-03-31
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA, 540-8645, JAPAN
Covered Properties
(5)
Combination Therapy for Cancer Treatment
Application:
15/551,093 →
Publication:
US 2018/0235986
Combination Therapy for Cancer Treatment
Application:
17/154,498 →
Publication:
US 2021/0137955
Combination Therapy for Cancer Treatment
Application:
17/392,158 →
Publication:
US 2021/0369748
Combination Therapy for Cancer Treatment
Application:
17/680,718 →
Publication:
US 2022/0184103
Combination Therapy for Cancer Treatment
Application:
17/903,507 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 12, 2018
From: LABOTKA, RICHARD; FERGUS, ANDREW
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 046852/0421 →
Assignment of Assignor's Interest
Jun 30, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056729/0503 →
Assignment of Assignor's Interest
Aug 5, 2021
From: LABOTKA, RICHARD; FERGUS, ANDREW
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 057086/0765 →